Robust humoral and cellular recall responses to azd1222 attenuate breakthrough sars-cov-2 infection compared to unvaccinated

HIGHLIGHTS

• who: Jill Maaske et al. from the Toscana Life Sciences, Italy University of Pavia, Italy have published the research work: Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated, in the Journal: (JOURNAL) of July/30,/2021
• what: The whiskers that extend from the box indicate the minimum and maximum after removing outliers (i.e., datapoints >1.5 x IQR from the box). breakthrough infections in this analysis, the authors wanted to determine whether the responders in were also capable of generating a T-cell response to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.